Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Rio Tinto (ADR) (RIO) vs Smith & Nephew plc (SNN) Price & Performance

Rio Tinto (ADR)Trade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Rio Tinto (ADR) vs Smith & Nephew plc — how do they compare? Rio Tinto (ADR) trades at $94.77 (market cap $150.89B), while Smith & Nephew plc trades at $27.23 (market cap $11.10B). The key difference: Rio Tinto (ADR) is far larger — about 13.6× Smith & Nephew plc's market cap, and Rio Tinto (ADR) pays the higher dividend (4.98%). Which is the better fit depends on your goals — on Pluang, investors hold Rio Tinto (ADR) for 10 Days and Smith & Nephew plc for 120 Days on average.

RIOSNN
Market Cap
$150.89B$11.10B
Volume
1,492,4441,051,703
Sector
Basic MaterialsHealth
52-Week High
$112.04$37.17
52-Week Low
$65.44$26.42
Typical Hold Time
10 Days120 Days
Enterprise Value
$164.24B$14.13B
Dividend Yield
4.98%2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rio Tinto (ADR)

No Aura AI signal available yet.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $26.89, near its 52-week low, with a bearish technical signal. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio, though the stock faces headwinds from analyst downgrades and CFO departure news.

The outlook is cautious; while fundamentals show profitability growth, the stock's proximity to lows and mixed analyst sentiment (26% buy, 65% hold) suggest limited near-term upside. Key risks include competitive pressures and execution challenges, but the stable dividend and institutional interest offer some support for patient investors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Rio Tinto (ADR)

Rio Tinto is a global mining company that produces metals and minerals including iron ore, aluminium, copper, and lithium. Its operations supply materials used in construction, manufacturing, transportation, and energy systems.

Read more on RIO →

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →